BRAT, Kristián, Michal SVOBODA, Jaromir ZATLOUKAL, Marek PLUTINSKÝ, Eva VOLAKOVA, Patrice POPELKOVA, Barbora NOVOTNA, Tomas DVORAK a Vladmir KOBLIZEK. The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients – A Prospective Multicenter Study. International Journal of Chronic Obstructive Pulmonary Disease. Albany: Dove Medical Press, 2021, roč. 16, April 2021, s. 1171-1182. ISSN 1178-2005. Dostupné z: https://dx.doi.org/10.2147/COPD.S297087.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients – A Prospective Multicenter Study
Autoři BRAT, Kristián (703 Slovensko, garant, domácí), Michal SVOBODA (203 Česká republika, domácí), Jaromir ZATLOUKAL (203 Česká republika), Marek PLUTINSKÝ (703 Slovensko, domácí), Eva VOLAKOVA (203 Česká republika), Patrice POPELKOVA (203 Česká republika), Barbora NOVOTNA (203 Česká republika), Tomas DVORAK (203 Česká republika) a Vladmir KOBLIZEK (203 Česká republika).
Vydání International Journal of Chronic Obstructive Pulmonary Disease, Albany, Dove Medical Press, 2021, 1178-2005.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30203 Respiratory systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.893
Kód RIV RIV/00216224:14110/21:00121546
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.2147/COPD.S297087
UT WoS 000648310100001
Klíčová slova anglicky chronic obstructive pulmonary disease; COPD; phenotypes; mortality; cluster; classification and regression tree; CART
Štítky 14110215, 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 17. 5. 2022 09:11.
Anotace
Introduction: The concept of phenotyping emerged, reflecting specific clinical, pulmonary and extrapulmonary features of each particular chronic obstructive pulmonary disease (COPD) case. Our aim was to analyze prognostic utility of: “Czech“ COPD phenotypes and their most frequent combinations, ”Spanish” phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages + groups in relation to long-term mortality risk. Methods: Data were extracted from the Czech Multicenter Research Database (CMRD) of COPD. Kaplan-Meier (KM) estimates (at 60 months from inclusion) were used for mortality assessment. Survival rates were calculated for the six elementary “Czech” phenotypes and their most frequent and relevant combinations, “Spanish” phenotypes, GOLD grades and groups. Statistically significant differences were tested by Log Rank test. An analysis of factors underlying mortality risk (the role of confounders) has been assessed with the use of classification and regression tree (CART) analysis. Basic factors showing significant differences between deceased and living patients were entered into the CART model. This showed six different risk groups, the differences in risk were tested by a Log Rank test. Results: The cohort (n=720) was 73.1% men, with a mean age of 66.6 years and mean FEV1 44.4% pred. KM estimates showed bronchiectases/COPD overlap (HR 1.425, p=0.045), frequent exacerbator (HR 1.58, p< 0.001), cachexia (HR 2.262, p< 0.001) and emphysematous (HR 1.786, p=0.015) phenotypes associated with higher mortality risk. Co-presence of multiple phenotypes in a single patient had additive effect on risk; combination of emphysema, cachexia and frequent exacerbations translated into poorest prognosis (HR 3.075; p< 0.001). Of the “Spanish” phenotypes, AE CB and AE non-CB were associated with greater risk of mortality (HR 1.787 and 2.001; both p=0.001). FEV1% pred., cachexia and chronic heart failure in patient history were the major underlying factors determining mortality risk in our cohort. Conclusion: Certain phenotypes (“Czech” or “Spanish”) of COPD are associated with higher risk of death. Co-presence of multiple phenotypes (emphysematous plus cachectic plus frequent exacerbator) in a single individual was associated with amplified risk of mortality.
Návaznosti
15/14/NAP, interní kód MUNázev: Sledování výskytu deficitu alfa 1 antitrypsinu u pacientů s těžkou formou CHOPN
Investor: Ministerstvo zdravotnictví ČR, Sledování výskytu deficitu alfa 1 antitrypsinu u pacientů s těžkou formou CHOPN
5/15/NAP, interní kód MUNázev: Diagnostika bronchogenního karcinomu u nemocných s těžkou formou CHOPN pomocí výpočetní tomografie
Investor: Ministerstvo zdravotnictví ČR, Diagnostika bronchogenního karcinomu u nemocných s těžkou formou CHOPN pomocí výpočetní tomografie
VytisknoutZobrazeno: 13. 7. 2024 13:59